FcγRIIIA expressed on NK cells can activate NK cell-induced cytotoxicity by recognizing the Fc portion of tumor-bound antibodies and releasing cytotoxic factors and cytokines that recruit and activate other immune cells with specific antitumor activity in the presence of tumor antigen-targeting antibodies (16). This evidence concerns the gene FCGR3A and neoplasm.